Co-Medication of Statins with Contraindicated Drugs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Co-Medication of Statins with Contraindicated Drugs

Published:2015-05-01 Issue:5 Volume:10 Page:e0125180
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Yang Bo Ram,Seong Jong-Mi,Choi Nam-Kyong,Shin Ju-Young,Lee Joongyub,Kim Ye-Jee,Kim Mi-Sook,Park Soyoung,Song Hong Ji,Park Byung-Joo

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials;JJ Brugts;BMJ,2009

2. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study;JR Downs;JAMA,1998

3. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials;JC LaRosa;JAMA,1999

4. Effect of pravastatin on cardiovascular events in women after myocardial infarction: the cholesterol and recurrent events (CARE) trial;SJ Lewis;J Am Coll Cardiol,1998

5. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients;EJ Mills;J Am Coll Cardiol,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring signals of myopathy associated with statin and contraindicated comedications in the realworld;Fundamental & Clinical Pharmacology;2023-10-11

2. Cancer Metabolism as a Therapeutic Target and Review of Interventions;Nutrients;2023-10-01

3. Prevalence and predictors of clinically significant statin–drug interactions among Yemeni patients taking statins for primary and secondary prevention of cardiovascular disease;Current Medical Research and Opinion;2022-05-13

4. Cancer Biomarkers: A Long and Tortuous Journey;Biomarkers of the Tumor Microenvironment;2022

5. A Narrative Review of Statin-Induced Rhabdomyolysis: Molecular Mechanism, Risk Factors, and Management;Drug, Healthcare and Patient Safety;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3